What are the normal newborn blood glucose (HGT) values at the end of the first 2 hours, at the 6th hour, and at the 24th hour of life?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Newborn Blood Glucose Values by Time of Life

Based on the most recent high-quality evidence, normal blood glucose (HGT) values for healthy term newborns show a physiological nadir at 2 hours of life with median values of 2.6-4.4 mmol/L (46.7-79.9 mg/dL), dropping to their lowest at 6 hours with values of 2.2-4.0 mmol/L (39.5-71.1 mg/dL), then rising to stabilize around 3.6 mmol/L (65 mg/dL) by 24 hours of life 1, 2.

Time-Specific Normal Values

First 2 Hours of Life

  • Median range: 2.6-4.4 mmol/L (46.7-79.9 mg/dL)
  • 10th percentile (lower limit of normal): 2.1 mmol/L (38 mg/dL)
  • This represents the initial transitional period where glucose levels are actively declining 1, 2

6th Hour of Life (Nadir Point)

  • Median range: 2.2-4.0 mmol/L (39.5-71.1 mg/dL)
  • 10th percentile (lower limit of normal): 2.3 mmol/L (41 mg/dL)
  • This is the lowest physiological point in the first day of life 1, 2
  • Hypoglycemia proportions in studies ranged from 7-24% during the first 6 hours 3

24th Hour of Life

  • Median: approximately 3.6 mmol/L (65 mg/dL)
  • 10th percentile (lower limit of normal): 2.6 mmol/L (47 mg/dL)
  • Glucose levels stabilize and begin approaching normal infant/child values 2

Clinical Context and Interpretation

The 2025 ILCOR guidelines emphasize that hypoglycemia definitions vary considerably in the literature, most commonly defined as <2.2 mmol/L (<40 mg/dL) or <2.6 mmol/L (<46 mg/dL), while hyperglycemia is typically defined as >8.3 mmol/L (>150 mg/dL) 3.

The 2018 ESPGHAN/ESPEN guidelines provide operational thresholds for intervention in newborns 4:

  • Single measurement <1 mmol/L (18 mg/dL) requires immediate action
  • Blood glucose <2 mmol/L (36 mg/dL) that remains low on repeat measurement requires intervention
  • Single measurement <2.5 mmol/L (45 mg/dL) with abnormal clinical signs requires intervention

Important Caveats

These values apply specifically to:

  • Healthy term newborns (≥37 weeks gestation)
  • Appropriate weight for gestational age
  • No maternal complications (diabetes, toxemia, hypertension)
  • Exclusively breastfed infants 1

Higher-risk populations (preterm, small for gestational age, large for gestational age, infants of diabetic mothers, those requiring resuscitation) have different glucose dynamics and require more intensive monitoring 3, 5.

Physiological Pattern

The glucose trajectory follows a predictable pattern 1, 2:

  1. Rapid decline from birth to 2 hours
  2. Continued decline to nadir at 6 hours
  3. Gradual rise from 6-20 hours
  4. Stabilization around 20-24 hours, approaching normal infant values (3.5-5.5 mmol/L) by 72 hours 6

This represents normal metabolic adaptation as the neonate transitions from continuous maternal glucose supply to intermittent feeding and endogenous glucose production.

Measurement Considerations

Blood gas analyzers provide the most accurate glucose measurements in newborns, as handheld meters are less reliable due to high hemoglobin and bilirubin levels 4. Standard laboratory testing may yield falsely low results due to ongoing glycolysis in samples 4.

Related Questions

What are the normal blood glucose values and recommended glycemic target ranges for neonates, including term and preterm infants?
What is the normal range for random blood glucose (RBG) levels in a pediatric patient?
In a patient with hyperosmolar hyperglycemic state whose glucose decreased from 33 mmol/L to 22 mmol/L after receiving 0.9% normal saline at 1 L/hour for 2 hours, with serum sodium unchanged at 132 mEq/L, what is the most appropriate next step in fluid management?
What is the recommended blood glucose target range during treatment of hyperosmolar hyperglycaemic state (HHS)?
How should insulin and dextrose be managed in a hyperosmolar hyperglycemic state patient whose blood glucose is 156 mg/dL?
What are the cause, pathophysiology, and treatment of biotinidase deficiency in a 6‑week‑old infant, and can a diagram of the disrupted metabolic pathway be provided?
What are the benefits of a GLP‑3 (triple agonist targeting GLP‑1, GIP, and glucagon receptors) therapy?
How concerned should I be about a complete blood count (CBC) showing white blood cell count (WBC) 16.0 ×10⁹/L, red blood cell count (RBC) 2.77 ×10¹²/L, hemoglobin 8.5 g/dL, hematocrit 26.7 %, mean corpuscular volume (MCV) 96.4 fL, red cell distribution width (RDW) 24.9 %, platelet count 178 ×10⁹/L, mean platelet volume (MPV) 12.3 fL, and nucleated red blood cells (NRBC) 16.5 % (absolute 2.6 ×10⁹/L)?
What are the recommendations for a woman of child‑bearing age taking levetiracetam (Keppra) who is planning pregnancy regarding continuation of the drug, dosing, folic acid supplementation, and possible alternative antiepileptic options?
What clinical signs should be monitored in a newborn delivered by cesarean section to a morbidly obese diabetic mother?
What are the differences between clopidogrel and apixaban?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.